You are here:
09 February 2021 / deal

Morgan Stanley, BofA Securities, and SVB Leerink act as joint book-running managers in connection with the IPO of Pharvaris on NASDAQ

Loyens & Loeff N.V. trad op als Nederlandse counsel voor Morgan Stanley, BofA Securities, en SVB Leerink, die optraden als joint book-running managers van de aanbieding. Oppenheimer & Co. en Kempen & Co traden op als co-managers.

Pharvaris N.V. (“Pharvaris”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, on 4 February 2021 announced the pricing of its upsized initial public offering of 8,270,500 of its ordinary shares at an initial public offering price of $20.00 per share, for total gross proceeds of approximately $165.4 million.

In addition, Pharvaris has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,240,575 ordinary shares at the public offering price less underwriting discounts and commissions. This over-allotment option was exercised on 5 February 2021 in full. The ordinary shares are expected to begin trading on the Nasdaq Global Select Market on 8 February 2021 under the symbol "PHVS."



Messrs. Schenk have reached an agreement with Argos Wityu

Argos Wityu acquires Schenk Transport

Argos Wityu acquires Schenk Transport, a logistics services provider for the transport of gasses and liquids. read more
The Legal 500 Private Equity Country Comparative Guide 2021

The Legal 500 Private Equity Country Comparative Guide 2021

Loyens & Loeff has contributed to the publication of the 2021 edition. read more
ECJ paves the way for broader application of VAT-group

ECJ paves the way for broader application of VAT-group

The ‘M-GmbH’ ruling of the European Court of Justice paves the way for a broader application of the VAT group than most EU countries currently apply. read more
Stay informed

Don't miss out. Stay up to date about our latest news and events.

Stay informed